Last reviewed · How we verify

NCT07012733

Thoracic Mobilization for Restrictive Lung Disease

Not yet recruiting NA Last updated 10 June 2025
What this trial tests

NA trial testing Thoracic mobilization in Restrictive Lung Disease in 24 participants. Not yet recruiting.

Timeline
9 June 2025
Primary endpoint
18 November 2025
26 December 2025

Quick facts

Lead sponsorChungnam National University Sejong Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment24
Start date9 June 2025
Primary completion18 November 2025
Estimated completion26 December 2025
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Chungnam National University Sejong Hospital

Who can join

19 and older, any sex, with Restrictive Lung Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the immediate effects of thoracic mobilization techniques on cough capacity, dyspnea, and pulmonary function in patients with restrictive lung disease. The intervention will be applied in a single session, and outcomes will be measured before and after the intervention to evaluate short-term physiological changes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Restrictive Lung Disease

Currently open trials in the same condition.

Other Chungnam National University Sejong Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07012733.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing